Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Education On-Demand: Live and Virtual Symposium at ASCO 2022

Recorded on Friday, June 3, 2022

Join CLL Society and PeerView Institute to learn updates on the latest CLL data from a panel of experts including Drs. Anthony Mato, Nicole Lamanna, Matthew Davids, and Catherine Coombs in this recorded event from ASCO 2022. Gain their insight into the practicalities of therapeutic planning, including safety considerations associated with BTKi, PI3Ki, BCL-2i, and CAR-T therapy. This Masterclass and Case Forum will include topics such as personalized, evidence-based selection of upfront treatment strategies; therapeutic planning based on safety considerations; collaborative management of adverse events; treatment sequencing in relapsed/refractory CLL; and preparing for novel combinatorial and cellular therapy strategies.

The symposium was geared towards healthcare professionals, but all are welcome to watch and learn. You will need to complete a short survey prior to watching the on-demand event.